Cerenome (PSTV) Current Assets (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Current Assets of $18.0 million for Q1 2026, up 65.88% year-over-year from $10.9 million in Q1 2025, and up 18.84% quarter-over-quarter from $15.2 million in Q4 2025.
Cerenome (PSTV) Current Assets (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Current Assets for 17 consecutive years, with $18.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 65.88% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at $18.0 million (up 65.88% YoY), while the FY2025 annual figure was $15.2 million, up 188.46% from the prior year.
- Current Assets rose to $18.0 million in Q1 2026 per PSTV's latest filing, from $15.2 million in the prior quarter.
- Across five years, Current Assets topped out at $22.1 million in Q1 2022 and bottomed at $4.2 million in Q1 2024.
- Historically, Current Assets has averaged $13.3 million across 5 years, with a median of $12.4 million in 2023.
- Annual changes were most pronounced in 2024 — Current Assets slumped 69.09% — and 2025, when it surged 227.85%.
- Plus Therapeutics' Current Assets stood at $21.8 million in 2022, then tumbled by 54.93% to $9.8 million in 2023, then plunged by 46.52% to $5.3 million in 2024, then soared by 188.46% to $15.2 million in 2025, then climbed by 18.84% to $18.0 million in 2026.
- Business Quant data shows PSTV's Current Assets at $18.0 million in Q1 2026, $15.2 million in Q4 2025, and $17.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 11.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.03 Mn |
| Dec 31, 2025 | 15.17 Mn |
| Sep 30, 2025 | 17.59 Mn |
| Jun 30, 2025 | 9.21 Mn |
| Mar 31, 2025 | 10.87 Mn |
| Dec 31, 2024 | 5.26 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 9.38 Mn |
| Mar 31, 2024 | 4.21 Mn |
| Dec 31, 2023 | 9.83 Mn |
| Sep 30, 2023 | 11.58 Mn |
| Jun 30, 2023 | 12.36 Mn |
| Mar 31, 2023 | 13.63 Mn |
| Dec 31, 2022 | 21.82 Mn |
| Sep 30, 2022 | 20.88 Mn |
| Jun 30, 2022 | 18.89 Mn |
| Mar 31, 2022 | 22.10 Mn |
| Dec 31, 2021 | 19.72 Mn |
| Sep 30, 2021 | 22.10 Mn |
| Jun 30, 2021 | 18.00 Mn |